臓器保存市場：ソリューション（UW、Custodial HTK、Perfadex）、技術（静的冷蔵、低体温、常温）、臓器（腎臓、肝臓、心臓）、エンドユーザー（移植センター、病院、専門クリニック）別 - 2026年までの世界市場予測

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2026

世界の臓器保存市場は、2021年の2億7000万米ドルから2026年には3億1700万米ドルに達すると予測され、年平均成長率は6.6%です。この市場の成長は、多臓器不全の発生率の増加、老年人口の増加、臓器移植および臓器... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年2月28日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	212	213	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の臓器保存市場は、2021年の2億7000万米ドルから2026年には3億1700万米ドルに達すると予測され、年平均成長率は6.6%です。この市場の成長は、多臓器不全の発生率の増加、老年人口の増加、臓器移植および臓器提供者の数の増加、臓器提供を奨励する取り組みの増加などが主な要因となっています。
しかし、臓器移植の高額な費用に関する懸念や特定の地域における宗教上の懸念が、この市場の成長をある程度制限すると予想されます。

"ソリューション市場で最大のシェアを誇るウィスコンシン大学(UW)"
ソリューションに基づき、UW、Custodial HTK、Perfadex、その他のソリューション（EuroCollins、Celsior）に分類されます。2020年では、UWソリューションが最も大きなシェアを占めています。UW溶液は、腎臓、肝臓、膵臓の洗浄・保存に使用される。臓器保存のゴールドスタンダードと言われる、最初の細胞内保存液である。

"常温機械灌流は予測期間において最も高いCAGRを記録すると予想される。"
常温機械灌流は、2021年から2026年の予測期間において、最高のCAGRをマークしました。常温灌流は、臓器の平均温度を維持し、細胞代謝、酸素化、栄養補給に不可欠な基質を供給することで生理的環境を再現する技術である。臓器の安全性と有効性を高め、移植前の修復を向上させると言われている。常温法は、移植片の再生を促進しながら、肝臓の炎症反応や虚血傷害のリスクを減らすと言われている。限界品質（高齢のドナーのものなど）の臓器でも、長期間の移植片生存と移植片機能低下の軽減の可能性があるため、常温機械灌流の意義はますます高まっている。
静置低温保存と低体温装置による灌流は、この分野に関わる他の技術である。

"臓器タイプ別では、腎臓が最大のシェアを占める"
臓器別では、腎臓がシェアを占めています。腎移植は末期腎不全（ESRD）や腎不全の患者に対する治療法として選択されると考えられており、糖尿病などがこのセグメントの成長の原因となっています。成人患者におけるESRDのその他の原因としては、多嚢胞性腎臓病や糸球体腎炎が挙げられます。糖尿病の発症率の上昇に伴い、ESRDまたは腎不全の患者数は増加すると予想され、腎臓移植の需要を後押しするものと思われます。さらに、移植片の生存期間と長期的な移植機能の改善により、腎臓移植は透析に代わる費用対効果の高い治療法となっています。肺、肝臓、腎臓、心臓などの主要臓器は、このセグメントの一部です。

"エンドユーザー別では、移植センターが最大のシェアを占める"
臓器保存市場は、エンドユーザーに基づいて、臓器移植センター、病院、専門クリニックに区分されます。2020年の臓器保存市場では、臓器移植センター部門が最大のシェアを占めています。世界中で移植センターが増加していることが、このエンドユーザー区分の受け入れを促進し、市場成長を後押しする重要な要因となっています。

"予測期間中、アジア太平洋地域が最も高い成長を遂げる"
アジア太平洋地域は、2021-2026年の予測期間中に最も高いCAGRで成長すると予想されます。アジア太平洋地域の市場成長を促進する主な要因としては、政府の有利な取り組み、人々の意識の向上、臓器提供の増加などが挙げられます。中国では、国民教育の強化、動員、臓器移植技術の進歩により、臓器提供率が向上しています。インドでは、医療インフラの急速な改善が、医療観光を促進しながら市場の成長を支えています。日本では、宗教上の問題があるにもかかわらず、臓器提供への意欲が旺盛なため、臓器提供率が向上しています。

主な参加者の内訳は以下のとおりです。
- 企業タイプ別：Tier1-35%、Tier2-45%、Tier3-20%。
- 役職別 - Cレベル-35％、ディレクターレベル-25％、その他-40
- 地域別：北米45％、欧州30％、アジア太平洋20％、中南米3％、中近東・アフリカ2

臓器保存市場の主要企業

臓器保存市場で活動する主なプレーヤーは、Paragonix Technologies（米国）、XVIVO Perfusion AB（スウェーデン）、Dr.Franz Köhler Chemie GmbH（ドイツ）、Essential Pharmaceuticals, LLC（米国）、TransMedics（米国）、OrganOx Limited（英国）、21st Century Medicine（米国）、Shanghai Genext Medical Technology（中国）、 Bridge to Life Limited（米国）、 Waters Medical Systems（米国）、 Preservation Solutions（米国）、 Carnamedica（ポーランド）、 Transplant Biomedicals（スペイン）、 Institut Georges Lopez（フランス）、 Global Transplant Solutions（米国）、 Avionord（イタリア）、 Organ Preservation Solutions（英国）、 EBERS（スペイン）、 S.A.C. （イタリア）、S.A.L.F.（イタリア）、Biochefa（ポーランド）、Vascular Perfusion Solutions（米国）、TX Innovations（オランダ）です。

調査範囲。
このレポートは臓器保存市場を分析し、ソリューション、技術、臓器タイプ、エンドユーザー、地域などの様々なセグメントに基づいて、この市場の市場規模および将来の成長性を推定することを目的としています。また、市場で入手可能な様々な臓器保存製品の製品ポートフォリオマトリックスも掲載しています。また、本市場の主要企業の競争力分析も行っており、企業プロファイル、製品提供、主要な市場戦略も併せて掲載しています。

本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいては、より大きな市場シェアを獲得するのに役立つことでしょう。本レポートを購入された企業は、以下の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。

本レポートでは、以下のポイントについて考察しています。
- 市場浸透度。臓器保存の世界市場におけるトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報。本レポートでは、この市場をソリューション、技術、臓器タイプ、エンドユーザー別に分析しています。
- 製品の強化/革新。臓器保存の世界市場における今後の動向と製品の発売に関する詳細な洞察
- 市場開拓。ソリューション、技術、臓器タイプ、エンドユーザー別に、有利な新興市場に関する包括的な情報
- 市場の多様化。世界の臓器保存市場における新製品や製品の強化、成長地域、最近の開発、投資に関する詳細な情報
- 競合の評価。世界の臓器保存市場における主要企業の市場シェア、成長戦略、製品提供、競争力のマッピング、能力に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 30
1.2.2 MARKET SEGMENTATION 30
FIGURE 1 ORGAN PRESERVATION MARKET SEGMENTATION 30
1.2.3 YEARS CONSIDERED FOR THE STUDY 31
1.3 CURRENCY 31
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 31
1.4 STAKEHOLDERS 32
1.5 LIMITATIONS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH APPROACH 34
2.2 RESEARCH METHODOLOGY DESIGN 34
FIGURE 2 ORGAN PRESERVATION MARKET: RESEARCH DESIGN 34
2.2.1 SECONDARY RESEARCH 35
2.2.1.1 Key data from secondary sources 36
2.2.2 PRIMARY DATA 36
FIGURE 3 PRIMARY SOURCES 37
2.2.2.1 Key data from primary sources 38
2.2.2.2 Insights from primary experts 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 39
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39
2.3 MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET 40
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
FIGURE 7 ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION 42
FIGURE 8 TOP-DOWN APPROACH 42
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ORGAN PRESERVATION MARKET (2021–2026) 43
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 45
FIGURE 11 DATA TRIANGULATION METHODOLOGY 45
2.5 MARKET RANKING ANALYSIS 45
2.6 ASSUMPTIONS FOR THE STUDY 46
2.7 LIMITATIONS 46
2.7.1 METHODOLOGY-RELATED LIMITATIONS 46
2.7.2 SCOPE-RELATED LIMITATIONS 46
2.8 RISK ASSESSMENT 47
TABLE 2 RISK ASSESSMENT: ORGAN PRESERVATION MARKET 47
3 EXECUTIVE SUMMARY 48
FIGURE 12 ORGAN PRESERVATION MARKET, BY SOLUTION,
2021 VS. 2026 (USD MILLION) 48
FIGURE 13 ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2021 VS. 2026 (USD MILLION) 49
FIGURE 14 ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2021 VS. 2026 (USD MILLION) 49
FIGURE 15 ORGAN PRESERVATION MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 50
FIGURE 16 GEOGRAPHIC ANALYSIS: ORGAN PRESERVATION MARKET 51
4 PREMIUM INSIGHTS 52
4.1 ORGAN PRESERVATION MARKET OVERVIEW 52
FIGURE 17 RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE GROWTH IN
THE GLOBAL ORGAN PRESERVATION MARKET 52
4.2 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION & COUNTRY 53
FIGURE 18 THE UNIVERSITY OF WISCONSIN SOLUTION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET IN 2020 53
4.3 ORGAN PRESERVATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 54
4.4 ORGAN PRESERVATION MARKET, BY REGION (2019–2026) 55
FIGURE 20 NORTH AMERICA TO DOMINATE THE ORGAN PRESERVATION MARKET TILL 2026 55
4.5 ORGAN PRESERVATION MARKET: DEVELOPED VS. DEVELOPING MARKETS 55
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING
THE FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
TABLE 3 MARKET DYNAMICS: ORGAN PRESERVATION MARKET 56
5.2.1 DRIVERS 57
5.2.1.1 Growing geriatric population and subsequent growth in cases of multiple organ failure 57
TABLE 4 GROWTH IN GERIATRIC POPULATION (ABOVE-65 AGE GROUP), BY REGION, 2019 VS. 2050 (MILLION) 57
5.2.1.2 Increasing initiatives to promote public awareness and encourage organ donation 57
5.2.1.3 Rising number of organ donors and growing adoption of solid organ transplantation procedures 58
TABLE 5 NUMBER OF ORGAN DONATIONS, 2020 59
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of organ transplantation 59
5.2.2.2 Religious concerns and misconceptions associated with
organ donation 59
5.2.3 OPPORTUNITIES 60
5.2.3.1 Growing healthcare investments 60
5.2.4 CHALLENGES 60
5.2.4.1 Significant gap between the number of organs donated and organs required annually 60
5.2.4.2 Development of artificial organs 61
5.3 INDUSTRY TRENDS 61
5.3.1 SINGLE-PORT ROBOT-ASSISTED KIDNEY TRANSPLANT 61
5.3.2 PIG-TO-HUMAN XENOTRANSPLANTATION 61
5.4 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 6 PORTER’S FIVE FORCES ANALYSIS 62
5.4.1 THREAT FROM NEW ENTRANTS 62
5.4.2 THREAT FROM SUBSTITUTES 63
5.4.3 BARGAINING POWER OF SUPPLIERS 63
5.4.4 BARGAINING POWER OF BUYERS 63
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.5 PRICING ANALYSIS 64
TABLE 7 AVERAGE SELLING PRICE OF ORGAN PRESERVATION BY SOLUTION AND
BY ORGANS 64
5.6 ECOSYSTEM ANALYSIS 64
FIGURE 22 ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS 64
5.7 VALUE CHAIN ANALYSIS 65
FIGURE 23 ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS 65
5.8 PATENT ANALYSIS 65
5.8.1 PATENT PUBLICATION TRENDS FOR ORGAN PRESERVATION 66
FIGURE 24 PATENT PUBLICATION TRENDS (2011–2022) 66
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 66
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ORGAN PRESERVATION PATENTS (JANUARY 2011–FEBRUARY 2022) 67
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ORGAN PRESERVATION PATENTS (JANUARY 2011–FEBRUARY 2022) 68
TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS IN THE ORGAN PRESERVATION MARKET, 2020–2021 68
5.9 REGULATORY LANDSCAPE 70
5.9.1 NORTH AMERICA 70
5.9.1.1 US 70
5.9.1.2 Canada 71
5.9.2 EUROPE 71
5.9.3 ASIA PACIFIC 71
5.10 IMPACT OF COVID-19 ON THE ORGAN PRESERVATION MARKET 72
6 ORGAN PRESERVATION MARKET, BY SOLUTION 73
6.1 INTRODUCTION 74
TABLE 9 ORGAN PRESERVATION MARKET, BY SOLUTION, 2019–2026 (USD MILLION) 74
TABLE 10 ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 75
6.2 UNIVERSITY OF WISCONSIN 75
6.2.1 UW SOLUTIONS COMPRISE METABOLICALLY INERT SUBSTRATES, WHICH ENABLE BETTER TRANSPLANTATION OUTCOMES—A KEY FACTOR DRIVING MARKET GROWTH 75
TABLE 11 ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY,
2019–2026 (USD MILLION) 76
6.3 CUSTODIOL HTK 76
6.3.1 DESPITE ITS LOW COST AND EASY DIFFUSION, THE DEMAND FOR HTK HAS DECLINED IN RECENT YEARS—A KEY FACTOR LIMITING MARKET GROWTH 76
TABLE 12 ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 77
6.4 PERFADEX 78
6.4.1 LAUNCH OF PERFADEX PLUS TO DRIVE MARKET GROWTH 78
TABLE 13 ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 78
6.5 OTHER SOLUTIONS 79
TABLE 14 OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
7 ORGAN PRESERVATION MARKET, BY TECHNIQUE 80
7.1 INTRODUCTION 81
TABLE 15 COMPARISON OF THE METHODS USED FOR ORGAN PRESERVATION 81
TABLE 16 ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 81
TABLE 17 ORGAN PRESERVATION TECHNIQUES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
7.2 STATIC COLD STORAGE 82
7.2.1 STATIC COLD STORAGE IS THE MOST WIDELY ADOPTED METHOD—
A KEY FACTOR DRIVING MARKET GROWTH 82
TABLE 18 STATIC COLD STORAGE: ADVANTAGES & DISADVANTAGES 83
TABLE 19 ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE, BY COUNTRY, 2019–2026 (USD MILLION) 83
7.3 HYPOTHERMIC MACHINE PERFUSION 84
7.3.1 ADVANTAGES ASSOCIATED WITH HYPOTHERMIC MACHINE PERFUSION, SUCH AS ENHANCED ORGAN PRESERVATION QUALITY AND SURVIVAL RATE, TO DRIVE MARKET GROWTH 84
TABLE 20 HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES 84
TABLE 21 ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019–2026 (USD MILLION) 85

7.4 NORMOTHERMIC MACHINE PERFUSION 85
7.4.1 TECHNOLOGICAL DEVELOPMENTS AND ADVANTAGES OF NORMOTHERMIC MACHINE PERFUSION TO DRIVE MARKET GROWTH 85
TABLE 22 NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES 86
TABLE 23 ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019–2026 (USD MILLION) 86
8 ORGAN PRESERVATION MARKET, BY ORGAN TYPE 87
8.1 INTRODUCTION 88
FIGURE 27 NUMBER OF ORGAN TRANSPLANTS GLOBALLY, 2020 88
TABLE 24 ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 88
8.2 KIDNEYS 89
8.2.1 KIDNEYS ARE THE MOST TRANSPLANTED ORGANS GLOBALLY—A KEY FACTOR DRIVING MARKET GROWTH 89
TABLE 25 NUMBER OF KIDNEY TRANSPLANTS IN MAJOR COUNTRIES, 2017–2020 89
TABLE 26 TOTAL KIDNEY TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020 90
FIGURE 28 US: NUMBER OF ESRD PATIENTS ADDED TO THE WAITING LIST FOR KIDNEY TRANSPLANTS, 2000–2018 90
FIGURE 29 US: COUNT AND RATE OF KIDNEY TRANSPLANTS IN PATIENTS UNDERGOING DIALYSIS, 2000–2018 91
TABLE 27 KIDNEY PRESERVATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91
8.3 LIVER 92
8.3.1 RISING PREVALENCE OF LIVER DISEASE AND GROWING CASES OF LIVER FAILURE TO DRIVE THE DEMAND FOR LIVER TRANSPLANTATION PROCEDURES 92
TABLE 28 NUMBER OF LIVER TRANSPLANTS IN MAJOR COUNTRIES, 2017–2020 93
TABLE 29 TOTAL LIVER TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020 93
TABLE 30 LIVER PRESERVATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 94
8.4 LUNGS 94
8.4.1 GROWTH IN COPD INCIDENCE BOOSTS THE DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS 94
TABLE 31 US: PREVALENCE OF COPD CASES IN MAJOR STATES, BY GENDER, 2018 95
TABLE 32 NUMBER OF LUNG TRANSPLANTS IN MAJOR COUNTRIES, 2017–2020 95
TABLE 33 TOTAL LUNG TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020 96
TABLE 34 LUNG PRESERVATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.5 HEART 97
8.5.1 ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES TO DRIVE MARKET GROWTH 97
TABLE 35 NUMBER OF HEART TRANSPLANTS IN MAJOR COUNTRIES, 2017–2020 97
TABLE 36 TOTAL HEART TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020 98
TABLE 37 HEART PRESERVATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
8.6 PANCREAS 99
8.6.1 GROWING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH 99
TABLE 38 NUMBER OF PANCREAS TRANSPLANTS IN MAJOR COUNTRIES, 2017–2020 99
TABLE 39 TOTAL PANCREAS TRANSPLANT CENTERS IN MAJOR COUNTRIES,
2019 VS. 2020 99
TABLE 40 PANCREAS PRESERVATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
9 ORGAN PRESERVATION MARKET, BY END USER 101
9.1 INTRODUCTION 102
TABLE 41 ORGAN PRESERVATION MARKET, BY END USER, 2019–2026 (USD MILLION) 102
9.2 ORGAN TRANSPLANT CENTERS 102
9.2.1 ORGAN TRANSPLANT CENTERS ARE THE MAJOR END USERS OF ORGAN PRESERVATION SOLUTIONS 102
FIGURE 30 NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 103
TABLE 42 ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 103
9.3 HOSPITALS 104
9.3.1 INCREASING INCIDENCE OF ACCIDENTAL INJURIES AND CHRONIC DISEASES TO DRIVE MARKET GROWTH 104
TABLE 43 ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 105
9.4 SPECIALTY CLINICS 105
9.4.1 INCREASING PREVALENCE OF END-STAGE DISEASES AND ORGAN FAILURE TO DRIVE MARKET GROWTH 105
TABLE 44 ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 106
10 ORGAN PRESERVATION MARKET, BY REGION 107
10.1 INTRODUCTION 108
FIGURE 31 CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE ORGAN PRESERVATION MARKET 108
FIGURE 32 TOTAL NUMBER OF ORGAN TRANSPLANTS IN SOME COUNTRIES,
2019 VS. 2020 109
TABLE 45 ORGAN PRESERVATION MARKET, BY REGION, 2019–2026 (USD MILLION) 109
10.2 NORTH AMERICA 110
FIGURE 33 NORTH AMERICA: ORGAN PRESERVATION MARKET SNAPSHOT 111
TABLE 46 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 47 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 112
TABLE 48 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 112
TABLE 49 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 113
TABLE 50 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 113
10.2.1 US 114
10.2.1.1 Growing cases of organ failure and underlining diseases to drive
the demand for organ transplantation in the US 114
TABLE 51 NUMBER OF ORGAN TRANSPLANTS IN THE US, 2017–2020 114
TABLE 52 WAITING LIST FOR ORGAN TRANSPLANTS (AS OF JANUARY 2022) 115
FIGURE 34 US: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 115
TABLE 53 US: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 116
TABLE 54 US: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 116
TABLE 55 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 116
TABLE 56 US: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 117
10.2.2 CANADA 117
10.2.2.1 Improved organ donation rates to drive growth in the market
in Canada 117
TABLE 57 CANADA: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 117
FIGURE 35 CANADA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020 118
TABLE 58 ACTIVE WAITING LIST FOR ORGAN TRANSPLANTS, 2019 118
TABLE 59 CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 119
TABLE 60 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 119
TABLE 61 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 119
TABLE 62 CANADA: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 120
10.3 EUROPE 120
TABLE 63 EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 121
TABLE 64 EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 121
TABLE 65 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 122
TABLE 66 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 122
TABLE 67 EUROPE: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 122
10.3.1 FRANCE 123
10.3.1.1 Increasing number of organ transplants and organ donor registrations promote future growth of the organ preservation market in France 123
TABLE 68 FRANCE: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 123
FIGURE 36 FRANCE: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 123
TABLE 69 FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 124
TABLE 70 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 124
TABLE 71 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 124
TABLE 72 FRANCE: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 125
10.3.2 SPAIN 125
10.3.2.1 Spain registered the second-highest deceased organ donation rate globally—a key factor driving market growth 125
TABLE 73 SPAIN: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 125
TABLE 74 SPAIN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2017–2019 126
FIGURE 37 SPAIN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020 126
TABLE 75 SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 126
TABLE 76 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 127
TABLE 77 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 127
TABLE 78 SPAIN: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 127
10.3.3 UK 128
10.3.3.1 Growth in the market in the UK is mainly driven by the increasing disease/disorder prevalence and favorable regulations 128
TABLE 79 UK: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 128
TABLE 80 UK: TOTAL NUMBER OF PATIENTS ON THE ACTIVE ORGAN TRANSPLANT WAITING LIST (AS OF APRIL 8, 2021) 129
FIGURE 38 UK: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020 129
TABLE 81 UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 130
TABLE 82 UK: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 130
TABLE 83 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 130
TABLE 84 UK: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 131
10.3.4 ITALY 131
10.3.4.1 Declining rate of organ donation and transplant due to COVID-19 limited market growth in 2020 131
TABLE 85 ITALY: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 131
TABLE 86 ITALY: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2020 132
FIGURE 39 ITALY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 132
TABLE 87 ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 132
TABLE 88 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 133
TABLE 89 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 133
TABLE 90 ITALY: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 133

10.3.5 GERMANY 134
10.3.5.1 Low organ donation and transplant rates form a major concern for the German market 134
TABLE 91 GERMANY: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 134
TABLE 92 GERMANY: TOTAL NUMBER OF PATIENTS ACTIVE ON THE ORGAN TRANSPLANT WAITING LIST, 2019–2021 135
FIGURE 40 GERMANY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 135
TABLE 93 GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 136
TABLE 94 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 136
TABLE 95 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 137
TABLE 96 GERMANY: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 137
10.3.6 REST OF EUROPE 137
TABLE 97 ROE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 138
TABLE 98 ROE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 138
TABLE 99 ROE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 139
TABLE 100 ROE: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.4 ASIA PACIFIC 139
FIGURE 41 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT 140
TABLE 101 APAC: ORGAN PRESERVATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 102 APAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 141
TABLE 103 APAC: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 141
TABLE 104 APAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 142
TABLE 105 APAC: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 142
10.4.1 CHINA 142
10.4.1.1 Growing awareness and adoption of laws favoring organ donation to drive market growth in China 142
TABLE 106 CHINA: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 143
FIGURE 42 CHINA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 143
TABLE 107 CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 144
TABLE 108 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 144
TABLE 109 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 144
TABLE 110 CHINA: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 145
10.4.2 INDIA 145
10.4.2.1 Lack of awareness is a key barrier to market growth in India 145
FIGURE 43 INDIA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 145
TABLE 111 INDIA: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 146
TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 146
TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 147
TABLE 114 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 147
TABLE 115 INDIA: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 147
10.4.3 JAPAN 148
10.4.3.1 Religious beliefs and lack of awareness limit market growth in Japan 148
TABLE 116 JAPAN: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 148
TABLE 117 JAPAN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST (AS OF MARCH 31, 2021) 148
FIGURE 44 JAPAN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 149
TABLE 118 JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 149
TABLE 119 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 150
TABLE 120 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 150
TABLE 121 JAPAN: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 150
10.4.4 REST OF ASIA PACIFIC 151
TABLE 122 ROAPAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 151
TABLE 123 ROAPAC: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 151
TABLE 124 ROAPAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 152
TABLE 125 ROAPAC: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 152
10.5 LATIN AMERICA 152
10.5.1 IMPLEMENTATION OF EDUCATIONAL PROGRAMS TO TRAIN PROFESSIONALS ON ORGAN RETRIEVAL AND TRANSPLANT PROCEDURES TO DRIVE MARKET GROWTH 152
TABLE 126 BRAZIL: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 153
FIGURE 45 BRAZIL: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020 153
TABLE 127 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 154
TABLE 128 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2019–2026 (USD MILLION) 154
TABLE 129 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2019–2026 (USD MILLION) 155
TABLE 130 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER,
2019–2026 (USD MILLION) 155
10.6 MIDDLE EAST & AFRICA 156
10.6.1 IMPLEMENTATION OF GOVERNMENT INITIATIVES AND POLICIES TO DRIVE MARKET GROWTH 156
TABLE 131 SAUDI ARABIA: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 156
TABLE 132 ISRAEL: NUMBER OF ORGAN TRANSPLANTS, 2017–2020 157
TABLE 133 UAE: NUMBER OF ORGAN TRANSPLANTS, 2018–2020 157
TABLE 134 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 157
TABLE 135 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019–2026 (USD MILLION) 158
TABLE 136 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019–2026 (USD MILLION) 158
TABLE 137 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER, 2019–2026 (USD MILLION) 159
11 COMPETITIVE LANDSCAPE 160
11.1 OVERVIEW 160
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 160
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ORGAN PRESERVATION MARKET 161
11.3 MARKET RANKING ANALYSIS 163
TABLE 138 ORGAN PRESERVATION MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020 163
11.4 COMPETITIVE BENCHMARKING 164
11.4.1 FOOTPRINT OF COMPANIES IN THE ORGAN PRESERVATION MARKET 164
TABLE 139 COMPANY ORGAN PRESERVATION SOLUTION & DEVICE FOOTPRINT 165
TABLE 140 COMPANY TECHNIQUE FOOTPRINT 166
TABLE 141 COMPANY REGIONAL FOOTPRINT 167
11.5 COMPETITIVE LEADERSHIP MAPPING 168
11.5.1 STARS 168
11.5.2 EMERGING LEADERS 168
11.5.3 PERVASIVE PLAYERS 168
11.5.4 PARTICIPANTS 169
FIGURE 46 ORGAN PRESERVATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 169
11.6 COMPETITIVE SCENARIO 170
11.6.1 PRODUCT LAUNCHES & APPROVALS 170
TABLE 142 PRODUCT LAUNCHES & APPROVALS, 2018–2022 170
11.6.2 DEALS 171
TABLE 143 DEALS, 2018–2022 171
11.6.3 OTHER DEVELOPMENTS 172
TABLE 144 OTHER DEVELOPMENTS, 2018–2022 172
12 COMPANY PROFILES 173
12.1 KEY PLAYERS 173
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 PARAGONIX TECHNOLOGIES, INC. 173
TABLE 145 PARAGONIX TECHNOLOGIES, INC.: BUSINESS OVERVIEW 173
12.1.2 XVIVO PERFUSION AB 177
TABLE 146 XVIVO PERFUSION AB: BUSINESS OVERVIEW 177
FIGURE 47 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2020) 178
12.1.3 DR. FRANZ KÖHLER CHEMIE GMBH 182
TABLE 147 DR. FRANZ KÖHLER CHEMIE GMBH: BUSINESS OVERVIEW 182
12.1.4 ESSENTIAL PHARMACEUTICALS, LLC
(A SUBSIDIARY OF ACCORD HEALTHCARE) 184
TABLE 148 ESSENTIAL PHARMACEUTICALS, LLC: BUSINESS OVERVIEW 184
12.1.5 TRANSMEDICS, INC. 186
TABLE 149 TRANSMEDICS, INC.: BUSINESS OVERVIEW 186
12.1.6 ORGANOX LIMITED 188
TABLE 150 ORGANOX LIMITED: BUSINESS OVERVIEW 188
12.1.7 21ST CENTURY MEDICINE 190
TABLE 151 21ST CENTURY MEDICINE: BUSINESS OVERVIEW 190
12.1.8 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. 192
TABLE 152 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 192
12.1.9 BRIDGE TO LIFE LIMITED 193
TABLE 153 BRIDGE TO LIFE LIMITED: BUSINESS OVERVIEW 193
12.1.10 WATERS MEDICAL SYSTEMS LLC 195
TABLE 154 WATERS MEDICAL SYSTEMS: BUSINESS OVERVIEW 195
12.1.11 PRESERVATION SOLUTIONS, INC. 196
TABLE 155 PRESERVATION SOLUTIONS, INC.: BUSINESS OVERVIEW 196
12.1.12 CARNAMEDICA 197
TABLE 156 CARNAMEDICA: BUSINESS OVERVIEW 197
12.1.13 TRANSPLANT BIOMEDICALS 198
TABLE 157 TRANSPLANT BIOMEDICALS: BUSINESS OVERVIEW 198
12.1.14 INSTITUT GEORGES LOPEZ 199
TABLE 158 INSTITUT GEORGES LOPEZ: BUSINESS OVERVIEW 199
12.1.15 GLOBAL TRANSPLANT SOLUTIONS 201
TABLE 159 GLOBAL TRANSPLANT SOLUTIONS: BUSINESS OVERVIEW 201
12.2 OTHER PLAYERS 202
12.2.1 AVIONORD 202
TABLE 160 AVIONORD: BUSINESS OVERVIEW 202
12.2.2 ORGAN PRESERVATION SOLUTIONS LTD. 203
TABLE 161 ORGAN PRESERVATION SOLUTIONS LTD.: BUSINESS OVERVIEW 203
12.2.3 EBERS 204
TABLE 162 EBERS: BUSINESS OVERVIEW 204
12.2.4 S.A.L.F. 206
TABLE 163 S.A.L.F.: BUSINESS OVERVIEW 206
12.2.5 BIOCHEFA 207
TABLE 164 BIOCHEFA: BUSINESS OVERVIEW 207
12.2.6 VASCULAR PERFUSION SOLUTIONS, INC. 208
TABLE 165 VASCULAR PERFUSION SOLUTIONS, INC.: BUSINESS OVERVIEW 208
12.2.7 TX INNOVATIONS 209
TABLE 166 TX INNOVATIONS: BUSINESS OVERVIEW 209
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 210
13.1 INSIGHTS FROM INDUSTRY EXPERTS 210
13.2 DISCUSSION GUIDE 211
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 215
13.4 AVAILABLE CUSTOMIZATIONS 217
13.5 RELATED REPORTS 217
13.6 AUTHOR DETAILS 218

ページTOPに戻る

Table of Contents

Summary

The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%. Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations.
However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent.

“The University of Wisconsin (UW) holds the largest market share in the solution market.”
Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and Other solutions (EuroCollins and Celsior). In 2020, the UW solution accounted for the largest share of the market. The UW solution is used for the flushing and storage of kidneys, liver, and pancreas. It was the first intracellular preservation medium, considered the gold standard for organ preservation.

“Normothermic Machine Perfusion is expected to register the highest CAGR in the forecast period.”
Normothermic machine perfusion marked the highest CAGR in the forecast period of 2021 to 2026. Normothermic perfusion is a technique that recreates the physiologic environment by maintaining average organ temperature and providing essential substrates for cellular metabolism, oxygenation, and nutrition. It is said to enhance the safety and efficacy of the organ and improve repair before transplantation. The normothermic technique is said to reduce the pro-inflammatory response in the liver and the risk of ischemic injuries while promoting graft regeneration. The possibility of long-term graft survival and reduced delayed graft functioning in organs of marginal quality (such as those from older donors) has made normothermic machine perfusion increasingly relevant.
Static cold storage and hypothermic machine perfusion are the other techniques involved in this segment.

“Kidneys hold the largest share in the market, by organ type.”
Kidneys accounts for a market share in the organ segment. Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) or kidney failure, diabetes, etc. are all cause for the growth of this segment. Other causes of ESRD in adult patients are polycystic kidney disease and glomerulonephritis. With the rising incidence of diabetes, the number of patients with ESRD or kidney failure is expected to increase, which will drive demand for kidney transplants. Moreover, improvements in graft survival and long-term graft function have made kidney transplantation a cost-effective alternative to dialysis. Major organs like Lungs, Liver, Kidney and Heart are a part of this segment.

“Transplant centers hold the largest share in the market, by end user.”
Based on end users, the organ preservation market is segmented into organ transplant centers, hospitals, and specialty clinics. In 2020, the organ transplant centers segment accounted for the largest share of the organ preservation market. The increasing number of transplant centers across the globe is the key factor driving the acceptance of this end-user segment and propelling the market growth.

“The Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2021–2026. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China. In India, rapid improvements in the country’s healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Organ Preservation Market

The key players operating in the organ preservation market include Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).

Research Coverage:
The report analyzes the organ preservation market and aims at estimating the market size and future growth potential of this market based on various segments such as solution, technique, organ type, end user, and region. The report also includes a product portfolio matrix of various organ preservation products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global organ preservation market. The report analyzes this market by solution, technique, organ type, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global organ preservation market
• Market Development: Comprehensive information on the lucrative emerging markets by solution, technique, organ type and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global organ preservation market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global organ preservation market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（organ）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

臓器保存市場：ソリューション（UW、Custodial HTK、Perfadex）、技術（静的冷蔵、低体温、常温）、臓器（腎臓、肝臓、心臓）、エンドユーザー（移植センター、病院、専門クリニック）別 - 2026年までの世界市場予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（organ）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?